CN102085283B - Traditional Chinese medicament for treating myositis ossificans - Google Patents

Traditional Chinese medicament for treating myositis ossificans Download PDF

Info

Publication number
CN102085283B
CN102085283B CN200910185831XA CN200910185831A CN102085283B CN 102085283 B CN102085283 B CN 102085283B CN 200910185831X A CN200910185831X A CN 200910185831XA CN 200910185831 A CN200910185831 A CN 200910185831A CN 102085283 B CN102085283 B CN 102085283B
Authority
CN
China
Prior art keywords
percent
traditional chinese
grams
blood
chinese medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN200910185831XA
Other languages
Chinese (zh)
Other versions
CN102085283A (en
Inventor
吴延义
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200910185831XA priority Critical patent/CN102085283B/en
Publication of CN102085283A publication Critical patent/CN102085283A/en
Application granted granted Critical
Publication of CN102085283B publication Critical patent/CN102085283B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a traditional Chinese medicament for treating myositis ossificans which is used in external application. The traditional Chinese medicament consists of the following raw materials in percentage by weight: 15 to 40 percent of root of angelica dahurica, 15 to 55 percent of dragon's blood, 10 to 25 percent of peach kernel, 5 to 15 percent of myrrh and 15 to 40 percent of crude rhubarb. The preparation method comprises the following steps of: drying the five types of traditional Chinese medicines in the sun, grinding the raw materials into uniform powder, screening the powder, adding a proper amount of liquor or boiled water to obtain paste used for being externally applied to an affected part once a day and 24 hours each time, wherein 10 days constitute one treatment course. The traditional Chinese medicament has the advantages of good curative effect, high curative ratio(above 35 percent), low cost, economy, safety, reliability and no toxic and side effect.

Description

A kind of Chinese medicine of treating myositis ossificans
(1), technical field:
The present invention relates to the field of Chinese medicines, be specifically related to a kind of Chinese medicine of treating myositis ossificans.
(2), background technology:
Myositis ossificans means the abnormal ossification phenomenon of the collagen property supporting tissue of tendon, ligament, aponeurosis (aponeuroses) and skeletal muscle.Bone property myositis belongs to the fracture late complication.Because bone and muscle all derive from embryo's mesoderm mesenchymal tissue in early days, that is to say that mesenchymal cell both can break up, develop into skeleton, also can break up, develop into muscle.After the adult, still exist in the muscle substrate and do not break up mesenchymal cell completely, fall in accident, when fracture such as athletic injury, vehicle accident take place, muscle sustains damage, and fiber necroses, and the primitive mesenchymal cell proliferation is repaired.Do factor such as powerful passive heavy massage stimulates down in the later stage of various damages, and they can not be differentiated to form the muscle cicatrix, and break up down to other direction: make in the muscle calcinosises in a large number, form the tissue of similar sclerotin.The hematoma that local wound causes also possibly stimulate at osteogenic factor to issue bone growth promotingization.Except muscle, fascia, tendon and periosteum etc. are organized also and can be taken place.Myositis ossificans is prone to betide positions such as elbow joint, knee joint.Show as hinge area swelling and pain, the joint is passive all limited with active movement.After going down, pain and swelling can touch a lump that the boundary line is clearly hard in the place ahead, joint.Nonelastic because of muscle, elbow joint is stretched in the wrong limited; Since lump stop that flexing is also obviously limited.Myositis ossificans has a strong impact on the normal function of site of pathological change, makes troubles for patient's daily life and work.According to current clinical medicine, the treatment that mostly undergos surgery of every myositis ossificans, but the danger of operation is very big; Careless slightly; Consequence is difficult to expect, and postoperative wound face is bigger, owing in operative treatment, moving roughly periosteum stripping and passive excessive tractive repeatedly; Ankylosis reaches to ossify and increases the weight of unsatisfactory curative effect on the contrary; What also have carries out western medical treatment, and expense is expensive, and weak effect can't fundamentally be cured.
(3), content of the present invention:
The purpose of this invention is to provide a kind of Chinese medicine of treating myositis ossificans, the treatment that need not to undergo surgery, expense is low, good effect, cure rate can reach more than 85%.
For achieving the above object, the Chinese medicine that the present invention is a kind of to treat myositis ossificans is that 10%-25% Semen Persicae, the 15%-40% Radix Angelicae Dahuricae, 15%-40% Radix Et Rhizoma Rhei, 5%-15% Sanguis Draxonis, 5%-15% Myrrha are formed by percentage by weight.
The Radix Angelicae Dahuricae is the samphire Xingan Radix Angelicae Dahuricae, angelica anomala, Radix angelicae dahuricae or the windproof root of Yunnan cattle in the present technique scheme, and the hot temperature of the Radix Angelicae Dahuricae has removing blood stasis with potent drugs blood, replenishes fresh blood, granulation promoting analgesic function.Classical literature " detailed outline " record: " control nasal sinusitis, epistaxis, toothache, supraorbital bone pain, the large intestine constipation due to pathogenic wind, bleeding urine, married woman's blood dizziness due to wind pathogen fortune, regurgitation of food from the stomach is told food; Separate the arsenic poison, snakebite, cutter arrow incised wound ".In the current clinical medicine, control illness such as hydrarthrosis, herpes zoster, psoriasis with the external of these article effective.
Sanguis Draxonis is the resin in babassu Sanguis Draxonis fruit and the trunk.Promoting blood circulation to remove blood stasis is arranged, analgesic therapy, hemostasia and promoting granulation is held back the effect of skin ulcer.Cure mainly treating swelling and pain by traumatic injury, ecchymoma due to internal injury; Continuous bleeding due to traumatic injury, scrofula, ecthyma unhealed for long time.Classical literature Tang Materia Medica record: " main the five internal organs pathogen, leukorrhagia, pain relieving, removing mass blood, gold creation meat ".During clinical medicine was used in modern times, Sanguis Draxonis is used as the blood circulation promoting and blood stasis dispelling medicine for external use, and was evident in efficacy.
Semen Persicae is the dry mature seed of rosaceous plant peach Prunus persica (L.) Batsch or mountain peach Prunus davidiana (Carr.) Franch..Semen Persicae can be abolished blood-retention, the Myrrha blood that looses, subduing swelling and relieving pain, granulation promoting.Classical literature " Bencao Jingshu " carries: " Semen Persicae, property be apt to removing blood stasis, diseases such as all blood depletion, blood is secret, blood is dry, blood stasis, stagnant blood, blood-retention, blood pain, upright the leading to of using, diffusing and do not have receipts, rush down and of no help ".The modern medicine clinical observation confirms that Semen Persicae has the improvement effect to blood flow retardance, the capable obstacle of blood, can make each internal organs respectively organize functional recovery normal.
Myrrha is the gum resin of olive subject plant myrrh or Alan's fort myrrh.Compendium of Material Medica record: " Olibanum is invigorated blood circulation, and the Myrrha blood that looses all can alleviating pain and detumescence, granulation promoting ".Be applied in clinically can loose blood, detumescence, pain relieving.Cure mainly traumatic injury, bones and muscles pain.
Radix Et Rhizoma Rhei is the dry root and rhizome of polygonum rheum palmatum, Rheum tanguticum or Rheum officinale.Promoting blood circulation and detumescence is arranged, the granulation promoting analgesic effect.That its pharmacological action mainly contains is antibiotic, antiviral, rush down down, hepatic cholagogic; Platelet increasing, promotion blood coagulation, hemostasis; Diuresis etc.
After earlier raw materials such as Semen Persicae, the Radix Angelicae Dahuricae, Radix Et Rhizoma Rhei, Sanguis Draxonis, Myrrha being removed impurity; Dry; Grind to form uniform smalls; Sieve, together hybrid packed by above-mentioned percentage by weight 10%-25% Semen Persicae, the 15%-40% Radix Angelicae Dahuricae, 15%-40% Radix Et Rhizoma Rhei, 5%-15% Sanguis Draxonis, 5%-15% Myrrha again.Because the Radix Angelicae Dahuricae has removing blood stasis with potent drugs blood, replenish fresh blood, granulation promoting analgesic function, Sanguis Draxonis has promoting blood circulation to remove blood stasis, analgesic therapy, hemostasia and promoting granulation is held back the effect of skin ulcer; Semen Persicae can be abolished blood-retention, the Myrrha blood that looses, subduing swelling and relieving pain; There is specially good effect aspects such as granulation promoting, so the present invention adopts Semen Persicae, the Radix Angelicae Dahuricae, Radix Et Rhizoma Rhei, Sanguis Draxonis, Myrrha compatibility to use, have the function of detumescence removing blood stasis with potent drugs, eliminating stagnation, promoting blood circulation to remove obstruction in the collateral, granulation promoting pain relieving; Can effectively improve local blood circulation, make the stasis of blood stagnate diffusingly, passages through which vital energy circulates logical again and swollenly disappear, pain is ended, knot looses; To treatment fall in accident, fracture such as athletic injury, vehicle accident and the myositis ossificans effect that causes is remarkable, cure rate reaches more than 85%.
During use, the present invention is added an amount of wine or boiled water furnishing pasty state, the external application injury, once a day, and each external application 24 hours, 10 days is a course of treatment.The present invention makes up a prescription according to the Therapeutic Principle of relaxing muscles and tendons to promote blood circulation, eliminating stasis to stop pain, promoting the flow of QI in the collateral by warming the meridian, hard masses softening and resolving, and rehabilitation is simpler, good effect, and cure rate reaches more than 85%, and is economical and practical, safe and reliable, has no side effect.
Clinical effectiveness of the present invention is added up as follows:
The routine number of accumulative total Cure Effectively Invalid Increase the weight of Cure rate Total effective rate
348 296 45 7 0 85% 98%
Through several years clinical practice statistics, the present invention treats myositis ossificans accumulative total 348 examples, cures 296 examples, effective 45 examples, and invalid 7 examples increase the weight of 0 example, and total effective rate reaches 98%.
(4), the specific embodiment:
Embodiment one: the Radix Angelicae Dahuricae 40 grams, Sanguis Draxonis 5 grams, Semen Persicae 25 grams, Myrrha 10 grams, Radix Et Rhizoma Rhei 20 grams.
Embodiment two: the Radix Angelicae Dahuricae 25 grams, Sanguis Draxonis 15 grams, Semen Persicae 15 grams, Myrrha 15 grams, Radix Et Rhizoma Rhei 40 grams.
Embodiment three: the Radix Angelicae Dahuricae 30 grams, Sanguis Draxonis 10 grams, Semen Persicae 20 grams, Myrrha 10 grams, Radix Et Rhizoma Rhei 30 grams.
Embodiment four: the Radix Angelicae Dahuricae 20 grams, Sanguis Draxonis 12 grams, Semen Persicae 18 grams, Myrrha 12 grams, Radix Et Rhizoma Rhei 38 grams.
Embodiment five: the Radix Angelicae Dahuricae 40 grams, Sanguis Draxonis 15 grams, Semen Persicae 22 grams, Myrrha 8 grams, Radix Et Rhizoma Rhei 15 grams.
Embodiment six: the Radix Angelicae Dahuricae 35 grams, Sanguis Draxonis 8 grams, Semen Persicae 10 grams, Myrrha 15 grams, Radix Et Rhizoma Rhei 32 grams.
Embodiment seven: the Radix Angelicae Dahuricae 38 grams, Sanguis Draxonis 13 grams, Semen Persicae 19 grams, Myrrha 5 grams, Radix Et Rhizoma Rhei 25 grams.
Five tastes medical material in the foregoing description is dried, is ground into uniform smalls, sieve the back by 20 the gram to 40 the gram pack finished product.
The present invention will be described below in conjunction with some cases;
Case: Pei, woman, 8 years old, Huaining County, Anhui Province flood people from town.Infant causes comminuted fracture on the left humerus condyle because of falling from two roofs before one month; Through certain hospital's expectant treatment, the external plaster fixation was found elbow joint stiffness when untiing fixedly after 20 days at that time; Joint stuffiness; Take the photograph in the locality sheet show the fracture para-position to line still can, press forearm and repeatedly give strong board, and advise parents of hospitalized children to help infant to do a large amount of passive activities of stretching.Patient's capped elbow aggravates bitterly after 2 weeks, dare not be movable, and ancon is stiff obviously, the forearm amyotrophy, a shuttle shape enclosed mass can be touched in the preceding inboard of elbow, and matter is hard, calm innervation.The X sheet shows: comminuted fracture on the left humerus condyle, the vaporific shade of inboard visible clouds before the ancon.Diagnosis: left elbow traumatic myositis ossificans; After use the present invention filled a prescription and treats 3 courses of treatment, ancon did not have tenderness, no lump.Function of joint and forearm muscle recovery are normal.
Case: Xu certain, man, 28 years old, people from Tongcheng City, Anhui Province.Fall from eminence and to cause right dislocation of the elbow joint companion fracture of head of radius, comminuted fracture of distal radius and being admitted to hospital, the treatment of row open reduction internal fixation is untied plaster slab and is fixed after January.The stiff limitation of activity of ancon, through functional exercise and passive activity, nothing was obviously improved in eight months; So capable again excision of radial head and elbow joint lysis are fixed one month through plaster slab, untie plaster slab, ancon is movable obviously limited and stiff; Forearm and biceps brachii m. amyotrophy can touch shuttle shape tuberosity before the elbow, after use the present invention fills a prescription and treats 5 courses of treatment; Elbow the place ahead shuttle shape tuberosity is to dissipate, and joint motion is clearly better, and it is normal that amyotrophy reaches basically.
Case 3: Zhang, 14 years old, people from Dongzhi County, Anhui Province; The careless left knee of damage by bike before 3 days, take the photograph sheet through local examination in hospital and be diagnosed as: 1/3 place's comminuted fracture under the fl adds ridge traction and small splints fixation before the shin through manual reduction; Take the photograph after 6 weeks the para-position of sheet fracture to line still can, lateral projection shows that rear side has the cloud shade, because of considering femoral inferior segment 6 weeks of comminuted fracture; Possibly be fresh growth of spur, not draw attention that the patella function completely loses to treat to remove union of fracture fixedly; Quadriceps femoris and Calf muscle atrophy are serious, do not see through nearly 2 months functional exercise and rehabilitation to be clearly better, and are diagnosed as myositis ossificans.Use 7 courses of treatment of face of the present invention treatment, the knee joint activity freely, amyotrophy also recovers basically.

Claims (1)

1. a Chinese medicine of treating myositis ossificans adopts outer application mode administration, it is characterized in that this Chinese medicine is that 10%-25% Semen Persicae, the 15%-40% Radix Angelicae Dahuricae, 15%-40% Radix Et Rhizoma Rhei, 5%-15% Sanguis Draxonis, 5%-15% Myrrha are formed by percentage by weight.
CN200910185831XA 2009-12-03 2009-12-03 Traditional Chinese medicament for treating myositis ossificans Active CN102085283B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910185831XA CN102085283B (en) 2009-12-03 2009-12-03 Traditional Chinese medicament for treating myositis ossificans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200910185831XA CN102085283B (en) 2009-12-03 2009-12-03 Traditional Chinese medicament for treating myositis ossificans

Publications (2)

Publication Number Publication Date
CN102085283A CN102085283A (en) 2011-06-08
CN102085283B true CN102085283B (en) 2012-03-28

Family

ID=44097444

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910185831XA Active CN102085283B (en) 2009-12-03 2009-12-03 Traditional Chinese medicament for treating myositis ossificans

Country Status (1)

Country Link
CN (1) CN102085283B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102631644B (en) * 2012-05-09 2013-12-04 严婉力 External-use traditional Chinese medicine for treating myositis ossificans
CN104906546A (en) * 2015-06-18 2015-09-16 张晓风 Traditional Chinese medicine preparation for treating traumatic myositis ossificans and preparation method thereof
CN104998102A (en) * 2015-06-29 2015-10-28 苗光丽 Externally applied drug for preventing myositis ossificans after elbow fracture
CN105031320A (en) * 2015-06-29 2015-11-11 李克军 Method for preparing externally applied medicament for myositis ossificans

Also Published As

Publication number Publication date
CN102085283A (en) 2011-06-08

Similar Documents

Publication Publication Date Title
CN101297946B (en) Plaster for activating blood and resolving stasis, dispelling wind and freeing collateral vessels and producing method thereof
CN100506274C (en) Traditional Chinese medicine for treating cervical vertebra disease
CN103156972A (en) Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury
CN105616824A (en) Bone reunion plaster and preparation method therefor
CN104771654A (en) Traditional Chinese medicine for treating lumbar vertebra hyperostosis and cervical vertebra hyperostosis and preparation method thereof
CN102085283B (en) Traditional Chinese medicament for treating myositis ossificans
CN100431577C (en) Medicine for treating femoral head necrosis and femur neck fracture and preparation method thereof
CN103169822B (en) Synovitis hui-nationality ointment and preparation method thereof
CN104721426A (en) Traditional Chinese medicine composition for promoting fracture healing
CN104147176A (en) Traditional Chinese medicine preparation for treating scapulohumeral periarthritis
CN104027532A (en) Traditional Chinese medicine fomentation paste for treating rheumatism
CN104161823B (en) A kind of Chinese medicine for the treatment of aseptic necrosis of femoral head
CN106728002A (en) A kind of medicinal liquor for treating traumatic injury
CN102370836B (en) External application traditional Chinese medicine for treating traumatic synovitis
CN100364603C (en) Externally used Chinese herbal medicinal composition
CN111358915A (en) Traditional Chinese medicine for treating congenital muscular torticollis and preparation method thereof
CN104524080A (en) Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method
CN110279746A (en) A kind of massage cream and preparation method thereof for treating traumatic injury
CN104027451B (en) A kind of Chinese medicine for the treatment of deficiency of the liver and kindey pattern of syndrome sciatica
CN112755134B (en) Plaster for treating hyperosteogeny and preparation method thereof
CN103585257A (en) Traditional Chinese medicine powder for treating fractures
CN108888736B (en) External-use bone reunion medicine and preparation method thereof
CN106474325A (en) A kind of Chinese medicine preparation for treating cervical spondylopathy and waist dish outstanding and preparation method thereof
CN105998260A (en) Traditional Chinese preparation for treating injury of knee joint meniscus and preparation method
CN100478007C (en) Plaster for treating traumatic injuries and rheumatism, and its prepn. method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant